[Problems and prospects for clinical heparin use].
The paper contains new data on the pharmacodynamics of heparin and its interaction with the Xa factor, antithrombin III and thrombin. A critical assessment of the clinical efficacy of different types of heparin treatment of thromboembolisms is given, including thromboembolism of the pulmonary artery.